Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-26 Sale | 2023-01-30 6:40 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 1,697 | $5.0799 | $8,621 | 11,853 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:50 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 1,309 | $5.3381 | $6,988 | 7,610 (Direct) | View |
| 2022-12-06 Sale | 2022-12-09 7:37 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance | 910 | $4.775 | $4,345 | 6,519 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 06:30 am | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance | 29,790 | $0.5353 | $15,947 | 214,368 (Direct) | View |
| 2021-05-11 Sale | 2021-05-12 8:44 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP Finance | 4,842 | $1.04 | $5,036 | 52,158 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-12 Exercise | 2023-04-14 7:17 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 50,000 | $0 | 61,853 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 5:11 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-01-26 Exercise | 2023-01-30 6:40 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 5,940 | $0 | 11,853 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 5:50 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 4,365 | $0 | 7,610 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-09 7:37 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance | 3,476 | $0 | 6,519 (Direct) | View |
| 2022-03-31 Option Award | 2022-03-31 5:15 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-28 07:00 am | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 06:30 am | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance | 115,000 | $0 | 214,368 (Direct) | View |
| 2021-09-29 Option Award | 2021-10-01 5:00 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance | 38,954 | $0 | 38,954 (Direct) | View |
| 2021-09-29 Other | 2021-10-01 5:00 pm | 2015-07-09 2024-07-09 | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP of Finance | 290,000 | $0 | 38,954 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:42 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP Finance | 240,000 | $0 | 240,000 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-12 8:44 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C CAO and VP Finance | 19,000 | $0 | 52,158 (Direct) | View |
| 2020-11-24 Option Award | 2020-11-27 5:09 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Chief Accounting Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2020-03-30 Option Award | 2020-04-01 8:30 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Vice President Finance | 114,000 | $0 | 114,000 (Direct) | View |
| 2019-08-28 Option Award | 2019-08-30 9:50 pm | 2020-08-28 2029-08-28 | TherapeuticsMD Inc. | TXMD | Donegan Michael C Vice President Finance | 120,000 | $0 | 120,000 (Direct) | View |